{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:44:57Z","timestamp":1778039097958,"version":"3.51.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/olq.0b013e318195762c","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T20:38:21Z","timestamp":1242938301000},"page":"290-296","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of HPV-DNA and Anti-HPV Antibodies in Women From Girardot, Colombia"],"prefix":"10.1097","volume":"36","author":[{"given":"Sandra","family":"Leon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel A.","family":"Patarroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Urquiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel E.","family":"Patarroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210213","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer.","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"R2-5-20210213","article-title":"An\u00e1lisis de la situaci\u00f3n del c\u00e1ncer c\u00e9rvico-uterino en America Latina y el Caribe.","author":"Lewis","year":"2004"},{"key":"R3-5-20210213","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer.","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-5-20210213","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002.","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"R5-5-20210213","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ijc.20894","article-title":"Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women.","volume":"115","author":"Rajeevan","year":"2005","journal-title":"Int J Cancer"},{"key":"R6-5-20210213","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2007\/914823","article-title":"The epidemiology of human papillomavirus infection and cervical cancer.","volume":"23","author":"Bosch","year":"2007","journal-title":"Dis Markers"},{"key":"R7-5-20210213","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ygyno.2005.11.035","article-title":"Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer.","volume":"102","author":"Ho","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R8-5-20210213","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0020-7292(01)00529-X","article-title":"Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions.","volume":"76","author":"Sun","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"R9-5-20210213","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"suppl 1","key":"R10-5-20210213","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections.","volume":"32","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"key":"R11-5-20210213","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.AOG.0000266984.23445.9c","article-title":"Socio-demographic factors associated with high-risk human papillomavirus infection.","volume":"110","author":"Kahn","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R12-5-20210213","first-page":"577","article-title":"Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay.","volume":"9","author":"Karem","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"R13-5-20210213","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ijc.10153","article-title":"Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58, and 59 virus-like particles in colombian women with invasive cervical cancer.","volume":"97","author":"Combita","year":"2002","journal-title":"Int J Cancer"},{"key":"R14-5-20210213","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/infdis\/172.1.19","article-title":"Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain.","volume":"172","author":"Nonnenmacher","year":"1995","journal-title":"J Infect Dis"},{"key":"R15-5-20210213","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/89.9.630","article-title":"Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.","volume":"89","author":"de Gruijl","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R16-5-20210213","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ijc.22176","article-title":"Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia.","volume":"120","author":"Einstein","year":"2007","journal-title":"Int J Cancer"},{"key":"R17-5-20210213","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1086\/315498","article-title":"Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.","volume":"181","author":"Carter","year":"2000","journal-title":"J Infect Dis"},{"key":"R18-5-20210213","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1055-9965.EPI-03-0191","article-title":"Natural history of human papillomavirus type 16 virus-like particle antibodies in young women.","volume":"13","author":"Ho","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R19-5-20210213","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ijc.2910500304","article-title":"Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children.","volume":"50","author":"Cason","year":"1992","journal-title":"Int J Cancer"},{"key":"R20-5-20210213","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1099\/vir.0.80077-0","article-title":"Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions.","volume":"85","author":"Rocha-Zavaleta","year":"2004","journal-title":"J Gen Virol"},{"key":"R21-5-20210213","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbrc.2005.04.115","article-title":"Two L1-peptides are excellent tools for serological detection of HPV-associated cervical carcinoma lesions.","volume":"332","author":"Urquiza","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R24-5-20210213","first-page":"1992","article-title":"The 2001 Bethesda System terminology.","volume":"68","author":"Apgar","year":"2003","journal-title":"Am Fam Physician"},{"key":"R25-5-20210213","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.bjc.6602049","article-title":"Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort.","volume":"91","author":"Peto","year":"2004","journal-title":"Br J Cancer"},{"key":"R26-5-20210213","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1155\/2007\/591826","article-title":"International standard reagents for HPV detection.","volume":"23","author":"Pagliusi","year":"2007","journal-title":"Dis Markers"},{"key":"R27-5-20210213","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S0036-46652003000300003","article-title":"Prevalence of human papillomavirus infection in rural villages of the Bolivian Amazon.","volume":"45","author":"Cervantes","year":"2003","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R28-5-20210213","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/j.1460-2075.1987.tb04731.x","article-title":"Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells.","volume":"6","author":"Seedorf","year":"1987","journal-title":"EMBO J"},{"key":"R29-5-20210213","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1073\/pnas.82.15.5131","article-title":"General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.","volume":"82","author":"Houghten","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"R30-5-20210213","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JCM.36.7.2046-2051.1998","article-title":"The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.","volume":"36","author":"Touze A","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R31-5-20210213","first-page":"145","article-title":"[ROC (receiver operating characteristics) curve: principles and application in biology].","volume":"63","author":"Delacour","year":"2005","journal-title":"Ann Biol Clin (Paris)"},{"key":"R32-5-20210213","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JCM.38.2.688-695.2000","article-title":"A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples.","volume":"38","author":"Nelson","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R33-5-20210213","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.239.4839.487","article-title":"Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.","volume":"239","author":"Saiki","year":"1988","journal-title":"Science"},{"key":"R34-5-20210213","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.2999980","article-title":"Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.","volume":"230","author":"Saiki","year":"1985","journal-title":"Science"},{"key":"R35-5-20210213","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1099\/0022-1317-76-4-1057","article-title":"The use of general primers GP5 and GP6 elongated at their 3\u2032 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.","volume":"76","author":"de Roda Husman","year":"1995","journal-title":"J Gen Virol"},{"key":"R36-5-20210213","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1128\/JCM.34.9.2095-2100.1996","article-title":"Use of multiple PCR primer sets for optimal detection of human papillomavirus.","volume":"34","author":"Karlsen","year":"1996","journal-title":"J Clin Microbiol"},{"key":"R37-5-20210213","first-page":"87","article-title":"Human papillomavirus type 18 in colorectal cancer.","volume":"34","author":"Lee YM","year":"2001","journal-title":"J Microbiol Immunol Infect"},{"key":"R38-5-20210213","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1386-6532(03)00114-8","article-title":"Evaluation of a convenient enzyme immunoassay to assess the quality of genital specimens submitted for the detection of human papillomavirus DNA by consensus PCR.","volume":"29","author":"Aho","year":"2004","journal-title":"J Clin Virol"},{"key":"R39-5-20210213","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/AEM.63.10.3741-3751.1997","article-title":"Inhibition and facilitation of nucleic acid amplification.","volume":"63","author":"Wilson","year":"1997","journal-title":"Appl Environ Microbiol"},{"key":"R40-5-20210213","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00007435-199611000-00012","article-title":"Risk factors for HPV DNA detection in middle-aged women.","volume":"23","author":"Munoz","year":"1996","journal-title":"Sex Transm Dis"},{"key":"R41-5-20210213","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/sti.79.6.474","article-title":"Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia","volume":"79","author":"Molano","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R42-5-20210213","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.bjc.6600442","article-title":"Prevalence and determinants of HPV infection among Colombian women with normal cytology.","volume":"87","author":"Molano","year":"2002","journal-title":"Br J Cancer"},{"key":"R43-5-20210213","first-page":"10","article-title":"Pap smear prevalence and that of pre-malignant and malignant cervical lesions amongst women living in the Carmen initiative demonstration area, Bucaramanga, Colombia.","volume":"57","author":"Uribe C","year":"2006","journal-title":"Rev Colomb Obstet Ginecol"},{"key":"R44-5-20210213","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007435-200905000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:36:11Z","timestamp":1618036571000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-200905000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e318195762c","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}